KD-6005
- Generic Name
- KD-6005
A Study of KD6005 in Healthy Participants and Participants With Rheumatoid Arthritis (RA)
- First Posted Date
- 2024-01-19
- Last Posted Date
- 2024-02-02
- Lead Sponsor
- Shanghai Kanda Biotechnology Co., Ltd.
- Target Recruit Count
- 72
- Registration Number
- NCT06213259
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath